Seventh Sense Biosystems Secures $5,500,000 New Financing Round

  • Feed Type
  • Date
    11/17/2016
  • Company Name
    Seventh Sense Biosystems
  • Mailing Address
    200 Boston Avenue Medford, MA 02155 USA
  • Company Description
    The company’s proprietary TAP Touch Activated Phlebotomy technology enables painless, convenient and safe blood collection and is the foundation for a rich pipeline of products from painless, one-step sampling to integrated collection and analysis for a total decentralized testing solution
  • Website
    http://www.7sbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 7 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy